Testosterone feminizing/masculinizing effects at 3.5 months: what's real

What did @c_j_y2025 actually say?

Technically, they didn't say much, medically speaking. The video is a lip-sync to what sounds like a song about family rejection of gender identity, with lyrics like "your mom don't get it and your dad don't get it" and references to being told to "wake up, go put on your makeup" and that transition is "just a phase." The caption does the real talking: 3.5 months on testosterone, using both T-gel and T-injection based on the hashtags. There are no medical claims here, just a personal update wrapped in a relatable anthem about unsupportive families. That context matters a lot for what we can and can't fact-check.

The creator is clearly a trans man in the early stages of hormone therapy. Early transition, roughly the 3-6 month window, is when many of the first noticeable physical changes from testosterone tend to appear. The video is emotional documentation, not medical advice, and we should treat it that way.

Does the science back this up?

The implied subtext, that family rejection is a real barrier trans people face and that being told transition is "just a phase" is harmful, is extremely well-supported by research. The medical content, using both gel and injectable testosterone at 3.5 months, is plausible and within the range of standard gender-affirming hormone therapy protocols.

Family rejection of transgender youth is not a minor inconvenience. A 2019 study by Turban et al. in Pediatrics found that transgender adults who experienced high levels of parental rejection in childhood had significantly elevated rates of depression and suicidal ideation compared to those with family support. The Trevor Project's 2023 National Survey on LGBTQ+ Youth Mental Health found that trans and nonbinary youth with at least one accepting adult were 40% less likely to report a suicide attempt in the past year. The song's framing of isolation and dismissal isn't dramatic. It reflects a documented public health reality.

On the hormone side, both transdermal gel and injectable testosterone are recognized formulations in gender-affirming care. The Endocrine Society's 2017 clinical practice guidelines (Hembree et al., Journal of Clinical Endocrinology and Metabolism) outline both as appropriate delivery methods, though they have different pharmacokinetic profiles.

What did they get wrong (or right)?

There's nothing medically wrong here because no medical claims were made. That's worth crediting. Too many trans health creators overclaim about timelines, doses, or expected results in ways that set people up for disappointment or worse. This creator shared an emotional milestone without pretending to be a clinician.

What they got right, implicitly, is that the psychological dimension of transition is inseparable from the physical one. The song choice communicates something real: that being on testosterone at 3.5 months doesn't automatically mean life is easier if the people around you are dismissive or hostile. Research backs this up hard. A 2022 study by Turban et al. in PLOS ONE found that gender-affirming hormone therapy was associated with lower odds of past-year suicidal ideation, but social support remained an independent predictor of mental health outcomes. Hormones help. Acceptance helps too. Neither replaces the other.

Using both gel and injections simultaneously is less common and worth noting without alarm. Some clinicians use combination approaches during titration phases, but if this creator is self-medicating or using two formulations without oversight, that carries real monitoring risks, including erratic serum testosterone levels and unpredictable hematocrit changes.

What should you actually know?

If you're at 3.5 months on testosterone, or thinking about starting, here's what the evidence actually supports:

• Early physical changes, including increased body hair, clitoral growth, and voice changes, typically begin within 1-6 months, but timelines vary significantly between individuals (Hembree et al., 2017, JCEM).
• Mental health benefits from gender-affirming hormone therapy are real and documented, but they are not guaranteed or universal. Concurrent psychological support improves outcomes.
• Using both injectable and topical testosterone at the same time is not standard practice and should only happen under direct clinical supervision with regular blood work to monitor testosterone levels, hematocrit, and lipid panels.
• Family rejection is a clinical risk factor, not just an emotional hardship. If your support system is hostile, that should be part of your conversation with a provider, not just a backdrop to your transition.
• "It's just a phase" is not a medically defensible position. Gender dysphoria is a recognized diagnosis, and gender-affirming care has a substantial evidence base supporting its benefits for appropriately screened patients.

This video doesn't give medical advice and shouldn't be treated as a clinical resource. But the emotional reality it documents, navigating early transition while managing family rejection, is a legitimate health context that providers and patients both need to take seriously.